Nuchal translucency measurement in fetuses with spinal muscular atrophy

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Prenatal Diagnosis

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pd.2646PMID 21287566
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased nuchal translucency in euploid fetuses—what should we be telling the parents?

  2010cited by this paper
• ACOG committee opinion No. 432: spinal muscular atrophy.

  2009cited by this paper
• ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities.

  2007cited by this paper
• Increased nuchal translucency with normal karyotype.

  2005cited by this paper
• [Fetal nuchal translucency].

  2005cited by this paper
• The association of spinal muscular atrophy type II and increased nuchal translucency

  2002cited by this paper
• Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester

  2001cited by this paper
• The association of increased fetal nuchal translucency and spinal muscular atrophy type I

  1999cited by this paper
• Outcome of fetuses with enlarged nuchal translucency and normal karyotype

  1998influential reference
• Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10–14 weeks of gestation

  1998cited by this paper
• Outcome and early childhood follow‐up of chromosomally normal fetuses with increased nuchal translucency at 10–14 weeks' gestation

  1998cited by this paper
• SONOGRAPHIC AND MATERNAL SERUM SCREENING ABNORMALITIES IN FETUSES AFFECTED BY SPINAL MUSCULAR ATROPHY

  1997influential reference
• Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.

  1992cited by this paper

• Antenatal Ultrasound Findings in Spinal Muscular Atrophy Type 0

  2025cites this paper
• The First Registered Type 0 Spinal Muscular Atrophy Patient in Latvia: Call for Change in Prenatal Diagnostic Procedures

  2023cites this paper
• The rst registered type 0 spinal muscular atrophy patient in Latvia: call for change in prenatal diagnostic procedures, case report

  2022cites this paper
• Prenatal diagnosis of 4953 pregnant women with indications for genetic amniocentesis in Northeast China

  2019cites this paper
• Prenatal chromosomal microarray analysis of fetus with increased nuchal translucency

  2018cites this paper
• Microarrays in prenatal diagnosis.

  2017cites this paper
• Developmental Aspects and Pathological Findings in Spinal Muscular Atrophy

  2017cites this paper
• Current controversies in prenatal diagnosis 3: is there still a value in a nuchal translucency screening ultrasound in conjunction with maternal plasma non‐invasive cell‐free DNA testing?

  2016cites this paper
• Perinatal Gene Therapy

  2016cites this paper
• Do the Levels of Maternal Plasma Trace Elements Affect Fetal Nuchal Translucency Thickness?

  2015cites this paper
• Genomic microarray in fetuses with increased nuchal translucency and normal karyotype: a systematic review and meta‐analysis

  2015cites this paper
• THESE POUR LE DOCTORAT EN MEDECINE

  2013cites this paper
• Raising obstetricians’ awareness of spinal muscular atrophy: towards early detection and reproductive planning

  2012cites this paper
• Further Evidence of No Association between Spinal Muscular Atrophy and Increased Nuchal Translucency

  2012cites this paper
• Increased nuchal translucency in the presence of normal chromosomes: what's next?

  2012cites this paper
• Candidate diseases for prenatal gene therapy.

  2012cites this paper
• Evaluation of fetal nuchal translucency in 98 pregnancies at risk for severe spinal muscular atrophy: possible relevance of the SMN2 copy number

  2012cites this paper
• Current World Literature

  2012cites this paper
• Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72 400 specimens

  2011cites this paper